Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Rudloff

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Kidney360|April 30, 2026
Left-Sided Weakness in a Kidney Transplant RecipientMichael Xu, Michael Rudloff, Koyal Jain
Oncotarget|December 22, 2016
Mesothelin-targeted immunotoxin RG7787 has synergistic anti-tumor activity when combined with taxanesEmily Kolyvas, Michael Rudloff, Marianne Poruchynsky, et al.
Molecular Cancer Research : MCR|November 3, 2019
Mesothelin Enhances Tumor Vascularity in Newly Forming Pancreatic Peritoneal MetastasesLeela Rani Avula, Michael Rudloff, Salma El-Behaedi, et al.
Toxins|November 3, 2018
Protein Synthesis Inhibition Activity of Mesothelin Targeting Immunotoxin LMB-100 Decreases Concentrations of Oncogenic Signaling Molecules and Secreted Growth FactorsSalma El-Behaedi, Rebekah Landsman, Michael Rudloff, et al.
Journal of Molecular and Cellular Cardiology|August 23, 2017
Novel obscurins mediate cardiomyocyte adhesion and size via the PI3K/AKT/mTOR signaling pathwayMaegen A Ackermann, Brendan King, Nicole A P Lieberman, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Kidney360|April 30, 2026
Left-Sided Weakness in a Kidney Transplant RecipientMichael Xu, Michael Rudloff, Koyal Jain
Oncotarget|December 22, 2016
Mesothelin-targeted immunotoxin RG7787 has synergistic anti-tumor activity when combined with taxanesEmily Kolyvas, Michael Rudloff, Marianne Poruchynsky, et al.
Molecular Cancer Research : MCR|November 3, 2019
Mesothelin Enhances Tumor Vascularity in Newly Forming Pancreatic Peritoneal MetastasesLeela Rani Avula, Michael Rudloff, Salma El-Behaedi, et al.
Toxins|November 3, 2018
Protein Synthesis Inhibition Activity of Mesothelin Targeting Immunotoxin LMB-100 Decreases Concentrations of Oncogenic Signaling Molecules and Secreted Growth FactorsSalma El-Behaedi, Rebekah Landsman, Michael Rudloff, et al.
Journal of Molecular and Cellular Cardiology|August 23, 2017
Novel obscurins mediate cardiomyocyte adhesion and size via the PI3K/AKT/mTOR signaling pathwayMaegen A Ackermann, Brendan King, Nicole A P Lieberman, et al.
Pageof 1